Centre To Convert 2,000 Agri Societies Into Jan Aushadhi Kendras

New Delhi : The Union government has identified 2,000 primary agricultural credit societies (PACS) to serve as Pradhan Mantri Bhartiya Jan Aushadhi Kendras, which are low-cost pharmacies selling unbranded medicines, which officials said would bolster last-mile health care delivery.

“One thousand centres will start functioning by August and the next 1,000 by December this year,” an official said, declining to be named. The move follows a plan to diversify these farm-service points and an agreement overseen by home minister Amit Shah and health minister Mansukh Mandaviya.

The cooperation ministry, also headed by Shah, is currently ramping up a drive to digitize PACS, which act as last-mile financial institutions for millions of farmers, which will enable them to diversify their business activities.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the chemicals and fertilizers ministry headed by Mandaviya in November 2008 to make quality generic medicines available at affordable prices. These dispensing facilities sell generic drugs that are 50-90% cheaper than branded drugs.

The Centre has rolled out changes to revamp the cooperative sector. At the heart of the overhaul is the plan to digitise PACS. India has nearly 800,000 cooperatives with a total membership base of about 290 million individuals, including banks, sugar mills and businesses, such as fertilizer-maker IFFCO and milk brand Amul. Cooperatives are collectives jointly owned by participating members who share profits and losses.

To be eligible to dispense drugs under the scheme, a primary cooperative society needs at least 120 sq. ft space, either privately owned or rented. The application fee for a Jan Aushadhi Kendra is ₹5,000. Women entrepreneurs, differently abled citizens, and scheduled castes and tribes get priority under special categories. All fees are waived off for applications from the special category, the official said.

  • Related Posts

    • Pharma
    • January 2, 2025
    • 28 views
    Kwality Pharma gains on securing RCGM approval for Erythropoietin

    Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…

    • Pharma
    • January 2, 2025
    • 230 views
    Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

    Sun Pharmaceutical Industries has announced the 100 per cent sale of its step-down subsidiary, Sun Pharma Japan Technical Operations, to Zaza Industrial Holdings K.K., Japan. The decision marks a strategic…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Kwality Pharma gains on securing RCGM approval for Erythropoietin

    Kwality Pharma gains on securing RCGM approval for Erythropoietin

    Man held with drugs worth Rs 2.50 cr, planned for New Year supply in Bengaluru

    Man held with drugs worth Rs 2.50 cr, planned for New Year supply in Bengaluru

    Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

    Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

    Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return

    Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return

    New Pharma Rules In India Effective Today: Are MSMEs Ready? What Will Change For The Industry

    New Pharma Rules In India Effective Today: Are MSMEs Ready? What Will Change For The Industry

    Sun Pharma To Sell 100 Percent Stake In Japanese Arm

    Sun Pharma To Sell 100 Percent Stake In Japanese Arm